For instance, Decitabine treatment of lymphoma cells reduced DNA methylation, thereby improving CD19 expression and favoring recognition by CD19 specific CAR-T cells both in patients with B-cell lymphoma and in vitro cultures (224). This evidence concerns the gene CD19 and B-cell non-Hodgkin lymphoma.